Home › Funds › EcoR1 Capital, LLC › PHAT

EcoR1 Capital, LLC position in PHAT

Phathom Pharmaceuticals, Inc. · Health Care

EcoR1 Capital, LLC reported holding 625,000 shares of PHAT (Phathom Pharmaceuticals, Inc.) in its Q2 2026 13F filing — a position valued at US$6.8M, representing 0.35% of its reported portfolio and ranking #24 among its reported holdings. EcoR1 Capital, LLC has disclosed PHAT holdings in 4 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)625.00K sh
Reported value held$6.78M
Portfolio Weight0.35%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How EcoR1 Capital, LLC's PHAT position evolved

EcoR1 Capital, LLC first disclosed a stake in PHAT in Q3 2023 at 700,000 shares (US$7.3M). Across 4 filings, EcoR1 Capital, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 625,000 shares valued at US$6.8M. Notable position changes include a 72% trim in Q4 2023 (shares rose 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 700.00K $7.26M New
Q4 2023 198.48K $1.81M Reduce
Q1 2026 625.00K $6.94M New
Q2 2026 625.00K $6.78M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PHAT and 13F data

PHAT (Phathom Pharmaceuticals, Inc.) is a Health Care company. 30 other funds we track also report a position in PHAT — the largest reported positions include Frazier Life Sciences Management, L.P. (US$135.3M), Medicxi Ventures Management (Jersey) Ltd (US$81.0M), Carlyle Group Inc. (US$37.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PHAT

All PHAT fund holders →

FAQ

How long has EcoR1 Capital, LLC held PHAT?

EcoR1 Capital, LLC has disclosed PHAT holdings in 4 of the last 12 reported quarters, going back to Q3 2023.

What is EcoR1 Capital, LLC's current position in PHAT?

As of Q2 2026, EcoR1 Capital, LLC holds 625.00K shares of PHAT (Phathom Pharmaceuticals, Inc.), valued at $6.78M, representing 0.35% of its reported portfolio and ranking #24.

Has EcoR1 Capital, LLC been buying or selling PHAT?

In the latest 13F filing (Q2 2026), EcoR1 Capital, LLC held unchanged its position in PHAT.

Which other funds hold PHAT?

Other major institutional holders of PHAT include Frazier Life Sciences Management, L.P., Medicxi Ventures Management (Jersey) Ltd, Carlyle Group Inc., among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.